Excellent response to bortezomib in a patient with widespread ulcerative pyoderma gangrenosum accompanied by pulmonary involvement and IgA monoclonal gammopathy

Int Wound J. 2019 Aug;16(4):1052-1054. doi: 10.1111/iwj.13135. Epub 2019 May 2.

Authors

Ecem Bostan¹, Sibel D Günaydın¹, Ayşen Karaduman¹, Sibel E Evans¹, Gonca Elçin¹, Duygu Gülseren¹, Müfide Okay², Lütfi Çöplü³

Affiliations

¹ Department of Dermatology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
² Department of Hematology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
³ Deparment of Chest Diseases, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents / therapeutic use*
Bortezomib / therapeutic use*
Humans
Immunoglobulin A / blood*
Lung Diseases / etiology*
Male
Pyoderma Gangrenosum / complications*
Pyoderma Gangrenosum / immunology*
Pyoderma Gangrenosum / physiopathology
Skin Ulcer / drug therapy*
Treatment Outcome

Substances

Antineoplastic Agents
Immunoglobulin A
Bortezomib